Stem cell manufacturing is a process which involves the production of stem cells with the ability to scale up stem cell processes. Stem cell therapy is growing rapidly and is used to treat diseases or injuries by introducing new adult stem cells into damaged tissue. It has the potential to impact human disease remarkably. These cells have the unique ability to replace damaged and diseased cells. Stem cell can adapt to different shape, sizes and has the ability to transform into a variety of cell types. Cells are manufactured to treat and aid different diseases such as cancer, heart disease, autoimmune disease and neurodegenerative diseases. Moreover, it is noted that raising awareness regarding the improved healthcare method has a robust impact on the growth of the global stem cell manufacturing market in the recent years.
The global stem cell manufacturing market is propelled by the increasing investment in stem cell-based research. Healthy development of genomic examination method for better manufacturing of stem cell and technological advancement in the development of stem cells an important factor for making the market demanding during the the assessed period. Otherkey factor which may push the market of stem cell manufacturing is the development of therapy-based treatment for geriatric people. Moreover, the increasing rates of bone marrow transplantation across the globe is also a major factor driving the growth of the stem cell manufacturing market. Additionally, healthcare infrastructure advancement for development of stem cell manufacturing types in emerging economies further expected to propel the market growth during the forecast period.
The global stem cell manufacturing market in the report is segmented by types which include hematopoietic stem cells, induced pluripotent stem cells, mesenchymal stem cells, and embryonic stem cells. Based on application, the market has been analyzed as drug discovery& development, allogenic stem cell therapy, autologous stem cell therapy, and cell & tissue banking. Moreover, the market of stem cell manufacturing is divided into end- user which includes healthcare& surgical centre, research organization, pharmaceutical companies, and others. Moving forward, the global stem cell manufacturing market has been geographically segmented into North America, Europe, Asia-Pacific, Middle East and Africa and Latin America.
In addition to this, increasing healthcare infrastructure along with skilled doctors and growing cancer patients in Asia-Pacific, makes the region holds the largest market share. Moreover, availability of research centre and growing pharmaceutical companies are mainly driving the European and North America market. Increasing focus on stem cell research in the U.S., Germany, Italy and France, has increased the demand for stem cell manufacturing market in both the regions. Moreover, the rapid growth of therapy-based treatment in countries like Brazil and Chile lifted the demand for stem cell manufacturing in Latin-America region. Increasing investment in stem cell-based research also fuels the growth for the stem cell manufacturing market in the Latin-America region. Moving forward, surging demand for stem cell manufacturing by the end- user industries which include healthcare & surgical centre, research organization, pharmaceutical companies, and others are projected to drive the Middle-East and Africa stem cell manufacturing market growth during the estimated period.
However, technical issue associated with manufacturing process may impose a restriction on the growth of the global stem cell manufacturing market.
Some of the major players in the global stem cell manufacturing includeAnterogen Co., Becton, Dickinson & Company, Bio-Rad Laboratories, Cellular Dynamics International, Lonza Group, Merk Group, MiltenyiBiotec, Osiris Therapeutics, and Pharmicell,
Global Stem Cell Manufacturing Market: By Types
Global Stem Cell Manufacturing Market: By Application
Global Stem Cell Manufacturing Market: By End- User
Global Stem Cell Manufacturing Market: By Geography